Grail, Inc. (NASDAQ:GRAL) Short Interest Update

Grail, Inc. (NASDAQ:GRAL) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 5,810,000 shares, an increase of 18.6% from the December 15th total of 4,900,000 shares. Approximately 20.2% of the shares of the company are short sold. Based on an average trading volume of 773,500 shares, the days-to-cover ratio is currently 7.5 days.

Insider Buying and Selling

In related news, CFO Aaron Freidin sold 30,452 shares of Grail stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $14.02, for a total value of $426,937.04. Following the completion of the transaction, the chief financial officer now directly owns 268,277 shares in the company, valued at approximately $3,761,243.54. The trade was a 10.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Hedge Funds Weigh In On Grail

Several hedge funds and other institutional investors have recently added to or reduced their stakes in GRAL. Wesbanco Bank Inc. bought a new stake in shares of Grail during the 4th quarter valued at about $523,000. B & T Capital Management DBA Alpha Capital Management purchased a new stake in Grail in the fourth quarter valued at approximately $387,000. 180 Wealth Advisors LLC bought a new stake in Grail during the fourth quarter valued at approximately $1,681,000. FNY Investment Advisers LLC purchased a new position in Grail in the 4th quarter worth approximately $26,000. Finally, A. D. Beadell Investment Counsel Inc. purchased a new position in Grail in the 4th quarter worth approximately $430,000.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Morgan Stanley started coverage on Grail in a research note on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price objective on the stock. Wolfe Research assumed coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating on the stock. Finally, Guggenheim started coverage on shares of Grail in a research report on Thursday, October 17th. They issued a “neutral” rating for the company.

Grail Stock Performance

Shares of Grail stock traded up $0.01 during trading on Friday, hitting $17.42. The stock had a trading volume of 483,860 shares, compared to its average volume of 868,233. Grail has a 12 month low of $12.33 and a 12 month high of $24.92. The company’s 50-day moving average price is $18.32.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.